CagrilintideCare & costs guide

Plain words. Clear questions.

← Back to the starting card

Source cards

Where can I check these answers?

Follow the source that answers your question. A study result cannot stand in for an approval record or an insurance rule.

What settles the pharmacy-made product question?

In September 2026, FDA, the US drug agency, said federal law did not permit compounding cagrilintide.

Compounding means a pharmacy mixes or makes a medicine for a patient.

The FDA page is the place to check that position. It matters before comparing a payment request.

Open the source note

Check FDA’s page before paying for an offer described as pharmacy-made.

What lets me check a study claim?

ClinicalTrials.gov is the government’s public list of studies. Find a cagrilintide study there using its NCT code, the reference number for that study.

Finding a study on that list does not prove the person offering you a place works with the study team.

Ask for the code and compare the study record with the offer. To check a claim about results, read the published study paper.

Open the source note

Look at the public study record for the medicine tested, who can take part and the study contacts. Look at the published paper for results.

Which sources answer the payment question?

Medicare’s temporary Bridge terms recorded in September 2026 apply to named eligible products and people, not to every weight-care offer.

Check the Medicare source for its rules. For a care fee, ask the service for a written quote. For money in a health account, ask the person or company that manages it which bills it can pay.

Open the source note

Check whether the program includes your medicine and whether you qualify before relying on its advertised price.

Which check comes next?

To check who is treating you, use the licence guide. To check your bill, use the cost questions. To ask whether insurance pays, use the coverage guide.

Another question worth asking

Start again with the drug name →